Delivery Order SPE2DX22D0010-SPE2D826FBS16

The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $53,658.52 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal healthcare vendor, supplying a comprehensive range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.

Under this delivery order, AmerisourceBergen provides pharmaceutical and medical supply support to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The vendor's federal contract portfolio demonstrates consistent capability in fulfilling military and veteran healthcare procurement requirements across multiple therapeutic areas, from diabetes and neurological medications to pain management pharmaceuticals, antibiotics, and specialized medical supplies. As a prime vendor under the DLA Troop Support Medical vehicle, AmerisourceBergen participates in a strategic approach enabling pharmaceutical support to military healthcare programs globally, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions and contractors.